Therapy News and Research

RSS

Acorda Therapeutics' AMPYRA now available in the U.S. and Puerto Rico

Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.

1 Mar 2010

ChemGenex Pharmaceuticals' OMAPRO review: FDA reschedules ODAC meeting to 22 March, 2010

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration (FDA) has rescheduled the previously postponed Oncologic Drugs Advisory Committee (ODAC) meeting to 22 March 2010.

1 Mar 2010

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of the SUmiT Trial of its Urgent® PC Neuromodulation System that will be published in the April 2010 print edition of THE JOURNAL OF UROLOGY® and is now available on line.

1 Mar 2010

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

1 Mar 2010

PPMG selected as agency of record for INADA massage chairs

The Pollack PR Marketing Group (PPMG) announced today, that it was selected as agency of record for INADA massage chairs (INADA), a leading designer and manufacturer of massage chairs.

1 Mar 2010

Oral immunotherapy promising for egg allergies, SLIT for milk allergies

Children with egg allergies who consume increasingly higher doses of egg protein - the very nutrient they react to - appear to gradually overcome their allergies, tolerating eggs better over time and with milder symptoms, according to research conducted at Johns Hopkins Children's Center and elsewhere.

1 Mar 2010

JACI supplement supports the importance of small airways in asthma management

Increasing evidence supports the importance of small airways in the diagnosis and treatment of asthma; however, focused areas of discussion and critical review of this topic have been lacking. To foster a better understanding of the role of small airways in asthma management, Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd., will be providing reprints of a special supplement entitled "Small Airway Involvement: A Key to Asthma" from the December issue of the Journal of Allergy and Clinical Immunology at their exhibit (Booth #724) at the American Academy of Allergy, Asthma & Immunology Annual Meeting being held Feb. 26-March 2, 2010 in New Orleans, La.

1 Mar 2010

Pharmacist workforce: Work characteristics and contributions

Results released today from the Pharmacy Manpower Project’s 2009 National Pharmacist Workforce Survey indicate shifts in the pharmacy profession toward more patient care. This 2009 report also provides insight into how the nation’s current economic situation has influenced the dynamics of the U.S. pharmacy workforce as nearly a quarter of pharmacists are practicing part-time and more are working past retirement age. This study is the third in a series of surveys commissioned by the Pharmacy Manpower Project, Inc. (PMP) since 2000 and has been highly anticipated throughout the industry.

1 Mar 2010

Using genetic engineering techniques in pigs, scientists create new model of diabetes

The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.

1 Mar 2010

Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partnership, drug sales up 7.6%

The Board of Directors of Ipsen, chaired by Jean-Luc Bélingard, met on 26 February 2010 to review the Group’s results for 2009, published today.

1 Mar 2010

New method using SGR to calculate rate of tumour growth developed

When treating cancer, it is an advantage to know the rate of growth of the cancer tumour. The standard method currently used to determine tumour growth, however, is erroneous. This is the conclusion of scientists at the University of Gothenburg, Sweden, who have developed a new model.

1 Mar 2010

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in the March issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

1 Mar 2010

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28.

1 Mar 2010

Smoking cessation: New nicotine lung delivery technology promising

A novel technology for delivering nicotine to the lungs may soon give smokers a new way to kick the habit.

1 Mar 2010

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.

1 Mar 2010

Reversing protein deficiency through gene therapy can improve SMA

Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.

1 Mar 2010

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Republicans and Democrat hit the Sunday talk shows today to debate whether a complex congressional process called 'reconciliation' should be used to consider a major overhaul of the U.S. health care system. Reconciliation is normally used for 'taxing and spending and reducing deficits,' said Sen.

28 Feb 2010

Ensure radiation therapy from certified technologists with ongoing qualifications

Every day in the United States, tens of thousands of patients are exposed to ionizing radiation through radiation therapy, CT scans, x rays, mammograms, and other medical imaging and therapeutic procedures. Patients need to have confidence that the technologists caring for them have the credentials and qualifications to safely administer radiation, and that the equipment they are using is properly calibrated and maintained to deliver radiation safely and within the proper dose parameters.

27 Feb 2010

Acculis' new device for destroying unwanted tissues receives European CE Mark clearance

Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. The device is a single high power high frequency 2.45GHz microwave needle that burns a 5cm sphere of tissue in just 5 minutes which is between 3 to 10 times faster than old school radiofrequency based systems or lower frequency 915MHz microwave systems.

27 Feb 2010

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

High-intensity, repetitive rehabilitation exercises can help stroke survivors significantly improve functioning in their paralyzed arm and in their quality of life — even years after their disabling event, according to late-breaking science results presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

Therapy News and Research

Acorda Therapeutics' AMPYRA now available in the U.S. and Puerto Rico

ChemGenex Pharmaceuticals' OMAPRO review: FDA reschedules ODAC meeting to 22 March, 2010

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

PPMG selected as agency of record for INADA massage chairs

Oral immunotherapy promising for egg allergies, SLIT for milk allergies

JACI supplement supports the importance of small airways in asthma management

Pharmacist workforce: Work characteristics and contributions

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partnership, drug sales up 7.6%

New method using SGR to calculate rate of tumour growth developed

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

Smoking cessation: New nicotine lung delivery technology promising

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Reversing protein deficiency through gene therapy can improve SMA

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Ensure radiation therapy from certified technologists with ongoing qualifications

Acculis' new device for destroying unwanted tissues receives European CE Mark clearance

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News